Recruiting GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance NCT04731272 Conditions Abnormal Glucose Tolerance, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, +16 more Locations Children's Hospital of Colorado — Aurora, Colorado, United States University of Pennsylvania — Philadelphia, Pennsylvania, United States View Trial Details
Not Yet Recruiting Verapamil Effect in Cystic Fibrosis-related Dysglycemia NCT07688070 Conditions Abnormal Glucose Tolerance, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, +8 more Locations Diabetes Research Center, Massachusetts General Hospital — Boston, Massachusetts, United States Rhode Island Hospital — Providence, Rhode Island, United States View Trial Details
Completed CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 NCT01773707 Conditions Abnormal Glucose Tolerance, Autoimmune Diseases, Diabetes Mellitus, +7 more Locations University of California - San Francisco — San Francisco, California, United States Stanford University Medical Center — Stanford, California, United States Barbara Davis Center for Childhood Diabetes, University of Colorado — Denver, Colorado, United States Yale Medical School — New Haven, Connecticut, United States View all 17 locations View more locations Show fewer locations Loading locations... View Trial Details
